The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Tuberculosis Vaccine Treatment Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The Tuberculosis Vaccine Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Tuberculosis Vaccine Treatment market size is estimated to be worth US$ 76 million in 2021 and is forecast to a readjusted size of USD 92 million by 2028 with a CAGR of 2.8% during review period. Self-Procurement accounting for % of the Tuberculosis Vaccine Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Immune Vaccine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Tuberculosis Vaccine Treatment include Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, and BioFarma, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Tuberculosis Vaccine Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Immune Vaccine
Therapy Vaccine
Market segment by Application can be divided into
Self-Procurement
UNICEF
Other
The key market players for global Tuberculosis Vaccine Treatment market are listed below:
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tuberculosis Vaccine Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tuberculosis Vaccine Treatment, with price, sales, revenue and global market share of Tuberculosis Vaccine Treatment from 2019 to 2022.
Chapter 3, the Tuberculosis Vaccine Treatment competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tuberculosis Vaccine Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Tuberculosis Vaccine Treatment market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Tuberculosis Vaccine Treatment.
Chapter 13, 14, and 15, to describe Tuberculosis Vaccine Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The Tuberculosis Vaccine Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Tuberculosis Vaccine Treatment market size is estimated to be worth US$ 76 million in 2021 and is forecast to a readjusted size of USD 92 million by 2028 with a CAGR of 2.8% during review period. Self-Procurement accounting for % of the Tuberculosis Vaccine Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Immune Vaccine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Tuberculosis Vaccine Treatment include Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, and BioFarma, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Tuberculosis Vaccine Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Immune Vaccine
Therapy Vaccine
Market segment by Application can be divided into
Self-Procurement
UNICEF
Other
The key market players for global Tuberculosis Vaccine Treatment market are listed below:
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tuberculosis Vaccine Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tuberculosis Vaccine Treatment, with price, sales, revenue and global market share of Tuberculosis Vaccine Treatment from 2019 to 2022.
Chapter 3, the Tuberculosis Vaccine Treatment competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tuberculosis Vaccine Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Tuberculosis Vaccine Treatment market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Tuberculosis Vaccine Treatment.
Chapter 13, 14, and 15, to describe Tuberculosis Vaccine Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Tuberculosis Vaccine Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Tuberculosis Vaccine Treatment Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Immune Vaccine
1.2.3 Therapy Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Tuberculosis Vaccine Treatment Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Self-Procurement
1.3.3 UNICEF
1.3.4 Other
1.4 Global Tuberculosis Vaccine Treatment Market Size & Forecast
1.4.1 Global Tuberculosis Vaccine Treatment Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Tuberculosis Vaccine Treatment Sales in Volume (2017-2028)
1.4.3 Global Tuberculosis Vaccine Treatment Price (2017-2028)
1.5 Global Tuberculosis Vaccine Treatment Production Capacity Analysis
1.5.1 Global Tuberculosis Vaccine Treatment Total Production Capacity (2017-2028)
1.5.2 Global Tuberculosis Vaccine Treatment Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Tuberculosis Vaccine Treatment Market Drivers
1.6.2 Tuberculosis Vaccine Treatment Market Restraints
1.6.3 Tuberculosis Vaccine Treatment Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Tuberculosis Vaccine Treatment Product and Services
2.1.4 Merck Tuberculosis Vaccine Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Japan BCG Lab
2.2.1 Japan BCG Lab Details
2.2.2 Japan BCG Lab Major Business
2.2.3 Japan BCG Lab Tuberculosis Vaccine Treatment Product and Services
2.2.4 Japan BCG Lab Tuberculosis Vaccine Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Serum Institute of India
2.3.1 Serum Institute of India Details
2.3.2 Serum Institute of India Major Business
2.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Product and Services
2.3.4 Serum Institute of India Tuberculosis Vaccine Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 AJ Vaccines
2.4.1 AJ Vaccines Details
2.4.2 AJ Vaccines Major Business
2.4.3 AJ Vaccines Tuberculosis Vaccine Treatment Product and Services
2.4.4 AJ Vaccines Tuberculosis Vaccine Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 BioFarma
2.5.1 BioFarma Details
2.5.2 BioFarma Major Business
2.5.3 BioFarma Tuberculosis Vaccine Treatment Product and Services
2.5.4 BioFarma Tuberculosis Vaccine Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 GreenSignal Bio Pharma
2.6.1 GreenSignal Bio Pharma Details
2.6.2 GreenSignal Bio Pharma Major Business
2.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product and Services
2.6.4 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 China National Biotec
2.7.1 China National Biotec Details
2.7.2 China National Biotec Major Business
2.7.3 China National Biotec Tuberculosis Vaccine Treatment Product and Services
2.7.4 China National Biotec Tuberculosis Vaccine Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Biomed Lublin
2.8.1 Biomed Lublin Details
2.8.2 Biomed Lublin Major Business
2.8.3 Biomed Lublin Tuberculosis Vaccine Treatment Product and Services
2.8.4 Biomed Lublin Tuberculosis Vaccine Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Taj Pharmaceuticals
2.9.1 Taj Pharmaceuticals Details
2.9.2 Taj Pharmaceuticals Major Business
2.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product and Services
2.9.4 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Ataulpho de Paiva
2.10.1 Ataulpho de Paiva Details
2.10.2 Ataulpho de Paiva Major Business
2.10.3 Ataulpho de Paiva Tuberculosis Vaccine Treatment Product and Services
2.10.4 Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 IVAC
2.11.1 IVAC Details
2.11.2 IVAC Major Business
2.11.3 IVAC Tuberculosis Vaccine Treatment Product and Services
2.11.4 IVAC Tuberculosis Vaccine Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Queen Saovabha Mem. Inst
2.12.1 Queen Saovabha Mem. Inst Details
2.12.2 Queen Saovabha Mem. Inst Major Business
2.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product and Services
2.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Microgen
2.13.1 Microgen Details
2.13.2 Microgen Major Business
2.13.3 Microgen Tuberculosis Vaccine Treatment Product and Services
2.13.4 Microgen Tuberculosis Vaccine Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Tuberculosis Vaccine Treatment Breakdown Data by Manufacturer
3.1 Global Tuberculosis Vaccine Treatment Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Tuberculosis Vaccine Treatment Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Tuberculosis Vaccine Treatment
3.4 Market Concentration Rate
3.4.1 Top 3 Tuberculosis Vaccine Treatment Manufacturer Market Share in 2021
3.4.2 Top 6 Tuberculosis Vaccine Treatment Manufacturer Market Share in 2021
3.5 Global Tuberculosis Vaccine Treatment Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Tuberculosis Vaccine Treatment Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Tuberculosis Vaccine Treatment Market Size by Region
4.1.1 Global Tuberculosis Vaccine Treatment Sales in Volume by Region (2017-2028)
4.1.2 Global Tuberculosis Vaccine Treatment Revenue by Region (2017-2028)
4.2 North America Tuberculosis Vaccine Treatment Revenue (2017-2028)
4.3 Europe Tuberculosis Vaccine Treatment Revenue (2017-2028)
4.4 Asia-Pacific Tuberculosis Vaccine Treatment Revenue (2017-2028)
4.5 South America Tuberculosis Vaccine Treatment Revenue (2017-2028)
4.6 Middle East and Africa Tuberculosis Vaccine Treatment Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Tuberculosis Vaccine Treatment Sales in Volume by Type (2017-2028)
5.2 Global Tuberculosis Vaccine Treatment Revenue by Type (2017-2028)
5.3 Global Tuberculosis Vaccine Treatment Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Tuberculosis Vaccine Treatment Sales in Volume by Application (2017-2028)
6.2 Global Tuberculosis Vaccine Treatment Revenue by Application (2017-2028)
6.3 Global Tuberculosis Vaccine Treatment Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Tuberculosis Vaccine Treatment Sales by Type (2017-2028)
7.2 North America Tuberculosis Vaccine Treatment Sales by Application (2017-2028)
7.3 North America Tuberculosis Vaccine Treatment Market Size by Country
7.3.1 North America Tuberculosis Vaccine Treatment Sales in Volume by Country (2017-2028)
7.3.2 North America Tuberculosis Vaccine Treatment Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Tuberculosis Vaccine Treatment Sales by Type (2017-2028)
8.2 Europe Tuberculosis Vaccine Treatment Sales by Application (2017-2028)
8.3 Europe Tuberculosis Vaccine Treatment Market Size by Country
8.3.1 Europe Tuberculosis Vaccine Treatment Sales in Volume by Country (2017-2028)
8.3.2 Europe Tuberculosis Vaccine Treatment Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Tuberculosis Vaccine Treatment Sales by Type (2017-2028)
9.2 Asia-Pacific Tuberculosis Vaccine Treatment Sales by Application (2017-2028)
9.3 Asia-Pacific Tuberculosis Vaccine Treatment Market Size by Region
9.3.1 Asia-Pacific Tuberculosis Vaccine Treatment Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Tuberculosis Vaccine Treatment Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Tuberculosis Vaccine Treatment Sales by Type (2017-2028)
10.2 South America Tuberculosis Vaccine Treatment Sales by Application (2017-2028)
10.3 South America Tuberculosis Vaccine Treatment Market Size by Country
10.3.1 South America Tuberculosis Vaccine Treatment Sales in Volume by Country (2017-2028)
10.3.2 South America Tuberculosis Vaccine Treatment Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Tuberculosis Vaccine Treatment Sales by Type (2017-2028)
11.2 Middle East & Africa Tuberculosis Vaccine Treatment Sales by Application (2017-2028)
11.3 Middle East & Africa Tuberculosis Vaccine Treatment Market Size by Country
11.3.1 Middle East & Africa Tuberculosis Vaccine Treatment Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Tuberculosis Vaccine Treatment Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Tuberculosis Vaccine Treatment and Key Manufacturers
12.2 Manufacturing Costs Percentage of Tuberculosis Vaccine Treatment
12.3 Tuberculosis Vaccine Treatment Production Process
12.4 Tuberculosis Vaccine Treatment Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Tuberculosis Vaccine Treatment Typical Distributors
13.3 Tuberculosis Vaccine Treatment Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Tuberculosis Vaccine Treatment Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Tuberculosis Vaccine Treatment Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Tuberculosis Vaccine Treatment Product and Services
Table 6. Merck Tuberculosis Vaccine Treatment Sales (K Dose), Price (USD/K Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Japan BCG Lab Basic Information, Manufacturing Base and Competitors
Table 8. Japan BCG Lab Major Business
Table 9. Japan BCG Lab Tuberculosis Vaccine Treatment Product and Services
Table 10. Japan BCG Lab Tuberculosis Vaccine Treatment Sales (K Dose), Price (USD/K Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 12. Serum Institute of India Major Business
Table 13. Serum Institute of India Tuberculosis Vaccine Treatment Product and Services
Table 14. Serum Institute of India Tuberculosis Vaccine Treatment Sales (K Dose), Price (USD/K Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. AJ Vaccines Basic Information, Manufacturing Base and Competitors
Table 16. AJ Vaccines Major Business
Table 17. AJ Vaccines Tuberculosis Vaccine Treatment Product and Services
Table 18. AJ Vaccines Tuberculosis Vaccine Treatment Sales (K Dose), Price (USD/K Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. BioFarma Basic Information, Manufacturing Base and Competitors
Table 20. BioFarma Major Business
Table 21. BioFarma Tuberculosis Vaccine Treatment Product and Services
Table 22. BioFarma Tuberculosis Vaccine Treatment Sales (K Dose), Price (USD/K Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. GreenSignal Bio Pharma Basic Information, Manufacturing Base and Competitors
Table 24. GreenSignal Bio Pharma Major Business
Table 25. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product and Services
Table 26. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales (K Dose), Price (USD/K Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. China National Biotec Basic Information, Manufacturing Base and Competitors
Table 28. China National Biotec Major Business
Table 29. China National Biotec Tuberculosis Vaccine Treatment Product and Services
Table 30. China National Biotec Tuberculosis Vaccine Treatment Sales (K Dose), Price (USD/K Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Biomed Lublin Basic Information, Manufacturing Base and Competitors
Table 32. Biomed Lublin Major Business
Table 33. Biomed Lublin Tuberculosis Vaccine Treatment Product and Services
Table 34. Biomed Lublin Tuberculosis Vaccine Treatment Sales (K Dose), Price (USD/K Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Taj Pharmaceuticals Major Business
Table 37. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product and Services
Table 38. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales (K Dose), Price (USD/K Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Ataulpho de Paiva Basic Information, Manufacturing Base and Competitors
Table 40. Ataulpho de Paiva Major Business
Table 41. Ataulpho de Paiva Tuberculosis Vaccine Treatment Product and Services
Table 42. Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales (K Dose), Price (USD/K Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. IVAC Basic Information, Manufacturing Base and Competitors
Table 44. IVAC Major Business
Table 45. IVAC Tuberculosis Vaccine Treatment Product and Services
Table 46. IVAC Tuberculosis Vaccine Treatment Sales (K Dose), Price (USD/K Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Queen Saovabha Mem. Inst Basic Information, Manufacturing Base and Competitors
Table 48. Queen Saovabha Mem. Inst Major Business
Table 49. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product and Services
Table 50. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales (K Dose), Price (USD/K Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Microgen Basic Information, Manufacturing Base and Competitors
Table 52. Microgen Major Business
Table 53. Microgen Tuberculosis Vaccine Treatment Product and Services
Table 54. Microgen Tuberculosis Vaccine Treatment Sales (K Dose), Price (USD/K Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Global Tuberculosis Vaccine Treatment Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Dose)
Table 56. Global Tuberculosis Vaccine Treatment Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 57. Market Position of Manufacturers in Tuberculosis Vaccine Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 58. Global Tuberculosis Vaccine Treatment Production Capacity by Company, (K Dose): 2020 VS 2021
Table 59. Head Office and Tuberculosis Vaccine Treatment Production Site of Key Manufacturer
Table 60. Tuberculosis Vaccine Treatment New Entrant and Capacity Expansion Plans
Table 61. Tuberculosis Vaccine Treatment Mergers & Acquisitions in the Past Five Years
Table 62. Global Tuberculosis Vaccine Treatment Sales by Region (2017-2022) & (K Dose)
Table 63. Global Tuberculosis Vaccine Treatment Sales by Region (2023-2028) & (K Dose)
Table 64. Global Tuberculosis Vaccine Treatment Revenue by Region (2017-2022) & (USD Million)
Table 65. Global Tuberculosis Vaccine Treatment Revenue by Region (2023-2028) & (USD Million)
Table 66. Global Tuberculosis Vaccine Treatment Sales by Type (2017-2022) & (K Dose)
Table 67. Global Tuberculosis Vaccine Treatment Sales by Type (2023-2028) & (K Dose)
Table 68. Global Tuberculosis Vaccine Treatment Revenue by Type (2017-2022) & (USD Million)
Table 69. Global Tuberculosis Vaccine Treatment Revenue by Type (2023-2028) & (USD Million)
Table 70. Global Tuberculosis Vaccine Treatment Price by Type (2017-2022) & (USD/K Dose)
Table 71. Global Tuberculosis Vaccine Treatment Price by Type (2023-2028) & (USD/K Dose)
Table 72. Global Tuberculosis Vaccine Treatment Sales by Application (2017-2022) & (K Dose)
Table 73. Global Tuberculosis Vaccine Treatment Sales by Application (2023-2028) & (K Dose)
Table 74. Global Tuberculosis Vaccine Treatment Revenue by Application (2017-2022) & (USD Million)
Table 75. Global Tuberculosis Vaccine Treatment Revenue by Application (2023-2028) & (USD Million)
Table 76. Global Tuberculosis Vaccine Treatment Price by Application (2017-2022) & (USD/K Dose)
Table 77. Global Tuberculosis Vaccine Treatment Price by Application (2023-2028) & (USD/K Dose)
Table 78. North America Tuberculosis Vaccine Treatment Sales by Country (2017-2022) & (K Dose)
Table 79. North America Tuberculosis Vaccine Treatment Sales by Country (2023-2028) & (K Dose)
Table 80. North America Tuberculosis Vaccine Treatment Revenue by Country (2017-2022) & (USD Million)
Table 81. North America Tuberculosis Vaccine Treatment Revenue by Country (2023-2028) & (USD Million)
Table 82. North America Tuberculosis Vaccine Treatment Sales by Type (2017-2022) & (K Dose)
Table 83. North America Tuberculosis Vaccine Treatment Sales by Type (2023-2028) & (K Dose)
Table 84. North America Tuberculosis Vaccine Treatment Sales by Application (2017-2022) & (K Dose)
Table 85. North America Tuberculosis Vaccine Treatment Sales by Application (2023-2028) & (K Dose)
Table 86. Europe Tuberculosis Vaccine Treatment Sales by Country (2017-2022) & (K Dose)
Table 87. Europe Tuberculosis Vaccine Treatment Sales by Country (2023-2028) & (K Dose)
Table 88. Europe Tuberculosis Vaccine Treatment Revenue by Country (2017-2022) & (USD Million)
Table 89. Europe Tuberculosis Vaccine Treatment Revenue by Country (2023-2028) & (USD Million)
Table 90. Europe Tuberculosis Vaccine Treatment Sales by Type (2017-2022) & (K Dose)
Table 91. Europe Tuberculosis Vaccine Treatment Sales by Type (2023-2028) & (K Dose)
Table 92. Europe Tuberculosis Vaccine Treatment Sales by Application (2017-2022) & (K Dose)
Table 93. Europe Tuberculosis Vaccine Treatment Sales by Application (2023-2028) & (K Dose)
Table 94. Asia-Pacific Tuberculosis Vaccine Treatment Sales by Region (2017-2022) & (K Dose)
Table 95. Asia-Pacific Tuberculosis Vaccine Treatment Sales by Region (2023-2028) & (K Dose)
Table 96. Asia-Pacific Tuberculosis Vaccine Treatment Revenue by Region (2017-2022) & (USD Million)
Table 97. Asia-Pacific Tuberculosis Vaccine Treatment Revenue by Region (2023-2028) & (USD Million)
Table 98. Asia-Pacific Tuberculosis Vaccine Treatment Sales by Type (2017-2022) & (K Dose)
Table 99. Asia-Pacific Tuberculosis Vaccine Treatment Sales by Type (2023-2028) & (K Dose)
Table 100. Asia-Pacific Tuberculosis Vaccine Treatment Sales by Application (2017-2022) & (K Dose)
Table 101. Asia-Pacific Tuberculosis Vaccine Treatment Sales by Application (2023-2028) & (K Dose)
Table 102. South America Tuberculosis Vaccine Treatment Sales by Country (2017-2022) & (K Dose)
Table 103. South America Tuberculosis Vaccine Treatment Sales by Country (2023-2028) & (K Dose)
Table 104. South America Tuberculosis Vaccine Treatment Revenue by Country (2017-2022) & (USD Million)
Table 105. South America Tuberculosis Vaccine Treatment Revenue by Country (2023-2028) & (USD Million)
Table 106. South America Tuberculosis Vaccine Treatment Sales by Type (2017-2022) & (K Dose)
Table 107. South America Tuberculosis Vaccine Treatment Sales by Type (2023-2028) & (K Dose)
Table 108. South America Tuberculosis Vaccine Treatment Sales by Application (2017-2022) & (K Dose)
Table 109. South America Tuberculosis Vaccine Treatment Sales by Application (2023-2028) & (K Dose)
Table 110. Middle East & Africa Tuberculosis Vaccine Treatment Sales by Region (2017-2022) & (K Dose)
Table 111. Middle East & Africa Tuberculosis Vaccine Treatment Sales by Region (2023-2028) & (K Dose)
Table 112. Middle East & Africa Tuberculosis Vaccine Treatment Revenue by Region (2017-2022) & (USD Million)
Table 113. Middle East & Africa Tuberculosis Vaccine Treatment Revenue by Region (2023-2028) & (USD Million)
Table 114. Middle East & Africa Tuberculosis Vaccine Treatment Sales by Type (2017-2022) & (K Dose)
Table 115. Middle East & Africa Tuberculosis Vaccine Treatment Sales by Type (2023-2028) & (K Dose)
Table 116. Middle East & Africa Tuberculosis Vaccine Treatment Sales by Application (2017-2022) & (K Dose)
Table 117. Middle East & Africa Tuberculosis Vaccine Treatment Sales by Application (2023-2028) & (K Dose)
Table 118. Tuberculosis Vaccine Treatment Raw Material
Table 119. Key Manufacturers of Tuberculosis Vaccine Treatment Raw Materials
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Tuberculosis Vaccine Treatment Typical Distributors
Table 123. Tuberculosis Vaccine Treatment Typical Customers
List of Figures
Figure 1. Tuberculosis Vaccine Treatment Picture
Figure 2. Global Tuberculosis Vaccine Treatment Revenue Market Share by Type in 2021
Figure 3. Immune Vaccine
Figure 4. Therapy Vaccine
Figure 5. Global Tuberculosis Vaccine Treatment Revenue Market Share by Application in 2021
Figure 6. Self-Procurement
Figure 7. UNICEF
Figure 8. Other
Figure 9. Global Tuberculosis Vaccine Treatment Revenue, (USD Million) & (K Dose): 2017 & 2021 & 2028
Figure 10. Global Tuberculosis Vaccine Treatment Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Tuberculosis Vaccine Treatment Sales (2017-2028) & (K Dose)
Figure 12. Global Tuberculosis Vaccine Treatment Price (2017-2028) & (USD/K Dose)
Figure 13. Global Tuberculosis Vaccine Treatment Production Capacity (2017-2028) & (K Dose)
Figure 14. Global Tuberculosis Vaccine Treatment Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Tuberculosis Vaccine Treatment Market Drivers
Figure 16. Tuberculosis Vaccine Treatment Market Restraints
Figure 17. Tuberculosis Vaccine Treatment Market Trends
Figure 18. Global Tuberculosis Vaccine Treatment Sales Market Share by Manufacturer in 2021
Figure 19. Global Tuberculosis Vaccine Treatment Revenue Market Share by Manufacturer in 2021
Figure 20. Tuberculosis Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Tuberculosis Vaccine Treatment Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Tuberculosis Vaccine Treatment Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2017-2028)
Figure 24. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region (2017-2028)
Figure 25. North America Tuberculosis Vaccine Treatment Revenue (2017-2028) & (USD Million)
Figure 26. Europe Tuberculosis Vaccine Treatment Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Tuberculosis Vaccine Treatment Revenue (2017-2028) & (USD Million)
Figure 28. South America Tuberculosis Vaccine Treatment Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Tuberculosis Vaccine Treatment Revenue (2017-2028) & (USD Million)
Figure 30. Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2017-2028)
Figure 31. Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2017-2028)
Figure 32. Global Tuberculosis Vaccine Treatment Price by Type (2017-2028) & (USD/K Dose)
Figure 33. Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2017-2028)
Figure 34. Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2017-2028)
Figure 35. Global Tuberculosis Vaccine Treatment Price by Application (2017-2028) & (USD/K Dose)
Figure 36. North America Tuberculosis Vaccine Treatment Sales Market Share by Type (2017-2028)
Figure 37. North America Tuberculosis Vaccine Treatment Sales Market Share by Application (2017-2028)
Figure 38. North America Tuberculosis Vaccine Treatment Sales Market Share by Country (2017-2028)
Figure 39. North America Tuberculosis Vaccine Treatment Revenue Market Share by Country (2017-2028)
Figure 40. United States Tuberculosis Vaccine Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Tuberculosis Vaccine Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Tuberculosis Vaccine Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Tuberculosis Vaccine Treatment Sales Market Share by Type (2017-2028)
Figure 44. Europe Tuberculosis Vaccine Treatment Sales Market Share by Application (2017-2028)
Figure 45. Europe Tuberculosis Vaccine Treatment Sales Market Share by Country (2017-2028)
Figure 46. Europe Tuberculosis Vaccine Treatment Revenue Market Share by Country (2017-2028)
Figure 47. Germany Tuberculosis Vaccine Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Tuberculosis Vaccine Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Tuberculosis Vaccine Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Tuberculosis Vaccine Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Tuberculosis Vaccine Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Tuberculosis Vaccine Treatment Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Tuberculosis Vaccine Treatment Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Tuberculosis Vaccine Treatment Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Tuberculosis Vaccine Treatment Revenue Market Share by Region (2017-2028)
Figure 56. China Tuberculosis Vaccine Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Tuberculosis Vaccine Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Tuberculosis Vaccine Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Tuberculosis Vaccine Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Tuberculosis Vaccine Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Tuberculosis Vaccine Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Tuberculosis Vaccine Treatment Sales Market Share by Type (2017-2028)
Figure 63. South America Tuberculosis Vaccine Treatment Sales Market Share by Application (2017-2028)
Figure 64. South America Tuberculosis Vaccine Treatment Sales Market Share by Country (2017-2028)
Figure 65. South America Tuberculosis Vaccine Treatment Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Tuberculosis Vaccine Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Tuberculosis Vaccine Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Tuberculosis Vaccine Treatment Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Tuberculosis Vaccine Treatment Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Tuberculosis Vaccine Treatment Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Tuberculosis Vaccine Treatment Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Tuberculosis Vaccine Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Tuberculosis Vaccine Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Tuberculosis Vaccine Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Tuberculosis Vaccine Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Tuberculosis Vaccine Treatment in 2021
Figure 77. Manufacturing Process Analysis of Tuberculosis Vaccine Treatment
Figure 78. Tuberculosis Vaccine Treatment Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
